Healthway Medical Corporation Limited announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2019. For the second quarter, the company announced revenue was SGD 28.234 million compared to SGD 28.644 million a year ago. Loss attributable to shareholders was SGD 677,000 compared to profit attributable to shareholders of SGD 78,000 a year ago. Basic and diluted loss per share was 0.01 cents. For the half year, revenue was SGD 55.333 million compared to SGD 57.304 million a year ago. Loss attributable to shareholders was SGD 1.754 million compared to profit attributable to shareholders of SGD 194,000 a year ago. Basic and diluted loss per share was 0.04 cents.